1-3 of 3
Chris Jones
Close
Sort by
Journal Articles

CD74 Is Expressed in Relapsed and Refractory Multiple Myeloma and Can be Targeted with a Novel Anti-CD74 Antibody Drug Conjugate, SΤRO-001

Millicent Embry, Xiaofan Li, PhD, Abigail Yu, PhD, Cristina Abrahams, PhD, Nancy Y. Greenland, MD PhD, Kwun Wah Wen, MD PhD, Chris Jones, Venita DeAlmeida, PhD, Stellanie Krimm, Sarah Krueger, PhD, Shannon Matheny, PhD, Toni Kline, PhD, Alice Yam, PhD, Ryan Stafford, PhD, Arun P. Wiita, MD PhD, Trevor Hallam, PhD, Mark Lupher, PhD, Arturo Molina, MDMS, FACP
Journal: Blood
Blood (2017) 130 (Supplement 1): 4420.
https://doi.org/10.1182/blood.V130.Suppl_1.4420.4420
Published: 2017
Journal Articles

Prognostic Factors in Primary Cutaneous Anaplastic Large Cell Lymphoma: Clinical and Molecular Characterization of a Subset with Worse Outcome.

Denise Woo, MD, Chris Jones, MD, Monique Vanoli-Storz, MD, Sabine Kohler, MD, Sunil Reddy, MD, Ranjana Advani, MD, Richard Hoppe, MD, Youn Kim, MD
Journal: Blood
Blood (2007) 110 (11): 3573.
https://doi.org/10.1182/blood.V110.11.3573.3573
Published: 2007
Journal Articles

Combined aCGH and Mutational Analysis of CLL Patients with 17p Deletion.

Hannah C. Rudenko, MSc, Vasantha Brito-Babapulle, PhD, David Gonzalez, PhD, Pilar Martinez, MD, Paola E. Leone, PhD, Chris Jones, PhD, Tim Dexter, PhD, Kerry Fenwick, MSc, Alan Mackay, BSc, Alan Ashworth, PhD, Estella Matutes, MD, Daniel Catovsky, MD, Claire Dearden, MD, Gareth J. Morgan, MD,PhD
Journal: Blood
Blood (2006) 108 (11): 2091.
https://doi.org/10.1182/blood.V108.11.2091.2091
Published: 2006